Related references
Note: Only part of the references are listed.Effectiveness of the 23-Valent Pneumococcal Polysaccharide Vaccine Against Community-Acquired Pneumonia in the General Population Aged ≥60 Years: 3 Years of Follow-up in the CAPAMIS Study
Olga Ochoa-Gondar et al.
CLINICAL INFECTIOUS DISEASES (2014)
Risk factors and pathogenic significance of bacteremic pneumonia in adult patients with community-acquired pneumococcal pneumonia
Cheol-In Kang et al.
JOURNAL OF INFECTION (2013)
Estimating the Burden of Pneumococcal Pneumonia among Adults: A Systematic Review and Meta-Analysis of Diagnostic Techniques
Maria A. Said et al.
PLOS ONE (2013)
Contribution of host, bacterial factors and antibiotic treatment to mortality in adult patients with bacteraemic pneumococcal pneumonia
Pontus Naucler et al.
THORAX (2013)
Retrospective epidemiological study for the characterization of community- acquired pneumonia and pneumococcal pneumonia in adults in a well-defined area of Badalona (Barcelona, Spain)
Antoni Sicras-Mainar et al.
BMC INFECTIOUS DISEASES (2012)
Rationale and design of the CAPAMIS study: Effectiveness of pneumococcal vaccination against community-acquired pneumonia, acute myocardial infarction and stroke
Angel Vila-Corcoles et al.
BMC PUBLIC HEALTH (2010)
Sustained Reductions in Invasive Pneumococcal Disease in the Era of Conjugate Vaccine
Tamara Pilishvili et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Epidemiology of Invasive Pneumococcal Disease among Adult Patients in Barcelona Before and After Pediatric 7-Valent Pneumococcal Conjugate Vaccine Introduction, 1997-2007
Carmen Ardanuy et al.
CLINICAL INFECTIOUS DISEASES (2009)
Pathogenesis, treatment, and prevention of pneumococcal pneumonia
Tom van der Poll et al.
LANCET (2009)
Invasive pneumococcal infections among persons with and without underlying medical conditions:: Implications for prevention strategies
Peter Klemets et al.
BMC INFECTIOUS DISEASES (2008)
Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults
Lionel A. Mandell et al.
CLINICAL INFECTIOUS DISEASES (2007)
Streptococcus pneumoniae:: Epidemiology, risk factors, and clinical features
Å Örtqvist et al.
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2005)
The influence of chronic illnesses on the incidence of invasive pneumococcal disease in adults
MH Kyaw et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Evaluation of the immunochromatographic binax NOW assay for detection of Streptococcus pneumoniae urinary antigen in a prospective study of community-acquired pneumonia in Spain
F Gutiérrez et al.
CLINICAL INFECTIOUS DISEASES (2003)
Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998 -: Opportunities for prevention in the conjugate vaccine era
KA Robinson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Pneumococcal disease among human immunodeficiency virus-infected persons: Incidence, risk factors, and impact of vaccination
MS Dworkin et al.
CLINICAL INFECTIOUS DISEASES (2001)
Cigarette smoking and invasive pneumococcal disease.
JP Nuorti et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997
DR Feikin et al.
AMERICAN JOURNAL OF PUBLIC HEALTH (2000)
Invasive pneumococcal infection in Baltimore, Md -: Implications for immunization policy
LH Harrison et al.
ARCHIVES OF INTERNAL MEDICINE (2000)
Share Paper
